Mark Tyndall - EVP & CLO and Corp Sec at Keenova Therapeutics plc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & CLO and Corp Sec
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Tyndall since 07 Jan 2025

Holdings reported by Mark Tyndall for Keenova Therapeutics plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 8,167 $724,821 $88.75 01 Jan 2026 Direct
Restricted Stock Units 46,031 01 Jan 2026 Direct Ordinary Shares

Transactions reported by Mark Tyndall for Keenova Therapeutics plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.